IREN Limited filings document an Australian public company reporting on AI cloud infrastructure, data center capacity, GPU deployments and related capital markets activity. Recent Form 8-K disclosures furnish quarterly operating and financial results, conference-call transcripts and press releases tied to the company’s AI cloud and data center platform.
The filing record also covers material-event disclosures for convertible senior notes, capped call use of proceeds, at-the-market ordinary-share issuance arrangements, and amendments to sales-agent agreements. Governance filings describe shareholder-approved constitutional changes, director-election provisions, meeting mechanics, forum selection language, universal proxy updates and the company’s omnibus incentive plan.
IREN Limited filed a post-effective amendment to its shelf registration and a prospectus supplement dated August 28, 2025, updating offerings under its Form S-3. The filing registers loan-funded shares and ordinary share resales, including up to 1,214,935 ordinary shares related to loan agreements and up to 2,000,000 ordinary shares potentially issuable to B. Riley Capital, LLC from exercisable options. A sales agreement prospectus supplement contemplates at-market sales under an amended issuance agreement with multiple dealers, including capacity to issue and sell up to $1,000,000,000 of ordinary shares under the sales agreement prospectus supplement.
The prospectus states use of any net proceeds for growth initiatives such as hardware purchases, data center development and working capital. It discloses key metrics: 271,980,494 ordinary shares outstanding as of August 15, 2025; 7,878,554 options outstanding at a weighted-average exercise price of $47.77; and 30,066,642 restricted share units outstanding. It reiterates material risks including Bitcoin price and global hashrate volatility, electricity and supply constraints, evolving tax and regulatory treatment of digital assets, potential litigation and financing risks, and that the last reported Nasdaq sale price was $22.36 on August 27, 2025.
IREN Limited filed a post-effective amendment to its shelf registration and a prospectus supplement dated August 28, 2025, updating offerings under its Form S-3. The filing registers loan-funded shares and ordinary share resales, including up to 1,214,935 ordinary shares related to loan agreements and up to 2,000,000 ordinary shares potentially issuable to B. Riley Capital, LLC from exercisable options. A sales agreement prospectus supplement contemplates at-market sales under an amended issuance agreement with multiple dealers, including capacity to issue and sell up to $1,000,000,000 of ordinary shares under the sales agreement prospectus supplement.
The prospectus states use of any net proceeds for growth initiatives such as hardware purchases, data center development and working capital. It discloses key metrics: 271,980,494 ordinary shares outstanding as of August 15, 2025; 7,878,554 options outstanding at a weighted-average exercise price of $47.77; and 30,066,642 restricted share units outstanding. It reiterates material risks including Bitcoin price and global hashrate volatility, electricity and supply constraints, evolving tax and regulatory treatment of digital assets, potential litigation and financing risks, and that the last reported Nasdaq sale price was $22.36 on August 27, 2025.
IREN Limited filed a current report to note that it has released its financial results for the fourth quarter and full fiscal year ended June 30, 2025.
The company announced these results in a press release dated August 28, 2025, which is furnished as Exhibit 99.1. This press release is provided for information but is not treated as formally filed for liability purposes or automatically incorporated into other securities filings.
IREN Limited filed a current report to note that it has released its financial results for the fourth quarter and full fiscal year ended June 30, 2025.
The company announced these results in a press release dated August 28, 2025, which is furnished as Exhibit 99.1. This press release is provided for information but is not treated as formally filed for liability purposes or automatically incorporated into other securities filings.
Schedule 13G/A (Amendment 2) filed 3 July 2025 discloses that The Awassi Capital Trust #2, Awassi Capital Holdings 2 Pty Ltd and Daniel John Roberts jointly own 6,251,247 ordinary shares of IREN Limited. This represents 2.41 % of IREN’s outstanding equity as of the event date 30 June 2025.
All voting and dispositive authority is shared; none of the three reporting persons holds sole power over the securities. The filing is made on Schedule 13G rather than 13D, signalling a passive investment posture with no intent to influence control. Because the stake is below the 5 % threshold, the group is no longer considered a “significant beneficial owner” under SEC rules, limiting its ability to affect governance matters or strategic direction.
- Reporting persons: The Awassi Capital Trust #2; Awassi Capital Holdings 2 Pty Ltd; Daniel John Roberts (all Australian)
- Shares owned: 6,251,247
- Percent of class: 2.41 %
- Sole voting/dispositive power: 0
- Shared voting/dispositive power: 6,251,247
No additional agreements, transactions, or changes of control are reported, and the certification states the information is true and complete.